Brought to you by:
The top 10 most popular Vascular Specialist stories of January 2024
In January, the most read stories from Vascular Specialist include a U.S. Aortic Research Consortium analysis of F/BEVAR preoperative risk factors in AAAs/TAAAs; a reflection on lessons learnt one year on from BEST-CLI; Southern Vascular’s election of its first female…
First patient treated in ZFEN+ fenestrated endovascular graft study
Cook Medical has announced the first patient treated in the clinical study of the Zenith Fenestrated+ endovascular graft (ZFEN+) in the U.S. The procedure was performed on Jan. 29, 2024, at the University of Texas Health (UTHealth) in Houston, Texas, by…
Gore receives FDA approval for breakthrough endovascular device in complex aortic aneurysms
Gore has announced Food and Drug Administration (FDA) approval for the Gore Excluder thoracoabdominal branch endoprosthesis (TAMBE), which the company states is the first off-the-shelf endovascular solution for the treatment of complex aneurysmal disease involving the visceral aorta. A press…
U.S. Aortic Research Consortium maps out F/BEVAR preoperative risk factors for one-year mortality in complex AAAs, TAAAs
A series of preoperative risk factors—including currently smoking, chronic kidney disease (CKD), congestive heart failure (CHF), aneurysm size greater than 7cm, more advanced age (75 or over), Crawford extent I–III thoracoabdominal aortic aneurysms (TAAAs), known chronic obstructive pulmonary disease (COPD),…
Preventing spinal cord ischemia: Novel techniques for direct segmental artery revascularization show promise, WVS 2023 hears
A vascular surgery team from the University of Southern California (USC) in Los Angeles demonstrated the feasibility of multidisciplinary direct revascularization of segmental arteries to prevent spinal cord ischemia (SCI) using novel endovascular or extra-anatomic bypass techniques in high-risk patients…
First implant of custom-made thoracoabdominal hybrid device in North America announced
Terumo Aortic announced the first North American implant of a custom-made hybrid device, Thoracoflo. A press release noted that the device is used to treat patients with thoracoabdominal aortic disease using a less invasive surgical technique than traditional open surgical…
‘Unique’ vascular meeting set to update surgeons, prioritize audience debate
Prioritizing “entertaining and informative” sessions, the 29th Annual Pennsylvania Hospital Vascular Symposium and the 3rd Annual Pennsylvania Hospital/University of Pennsylvania Non-invasive Vascular Laboratory Symposium (April 21–22) in Philadelphia returns, providing the latest open surgical and endovascular management of vascular disease.…
Cydar Medical and King’s College London partner on randomized controlled trial of Cydar EV Maps
Cydar Medical has partnered with King’s College London to initiate the ARIA study—a randomized controlled trial to assess the clinical-, technical- and cost-effectiveness of a cloud-based, artificially intelligent image fusion system in comparison to standard treatment to guide endovascular aortic…
Off-the-shelf branched endograft for TAAAs demonstrates safety and effectiveness through two years in both stable, symptomatic patients
Two-year target vessel-related freedom from all-cause and aneurysm-related mortality for an off-the-shelf multibranched endovascular device for the treatment of thoracoabdominal aortic aneurysms (TAAAs) came in at 78.5% and 98.6%, 2022 Vascular Annual Meeting (VAM) attendees heard. The data relate to…
F/BEVAR has high technical success and low mortality in chronic post-dissection TAAA
Fenestrated/branched endovascular aneurysm repair (F/BEVAR) is associated with high technical success and low mortality in patients with chronic post-dissection thoracoabdominal aortic aneurysm (PD-TAAA). This conclusion was presented by Mohamed A. Abdelhalim, MBChB, a PhD research fellow at St Thomas’ Hospital,…